Ecor1 Capital, Llc |
Non-Executive |
ANAPTYSBIO, INC (ANAB)
|
2024-08-14 |
$36.50 |
0.8% |
273,972
|
$9,999,978 |
Ecor1 Capital, Llc |
Non-Executive |
Zymeworks Inc. (ZYME)
|
2023-06-16 |
$8.12 |
44.8% |
3,350,000
|
$27,202,000 |
Ecor1 Capital, Llc |
Non-Executive |
Zymeworks Inc. (ZYME)
|
2023-03-28 |
$8.00 |
47.0% |
200,000
|
$1,600,000 |
Ecor1 Capital, Llc |
Non-Executive |
Zymeworks Inc. (ZYME)
|
2023-01-20 |
$9.70 |
21.2% |
307,500
|
$2,982,733 |
Ecor1 Capital, Llc |
Non-Executive |
Zymeworks Inc. (ZYME)
|
2023-01-18 |
$9.84 |
19.5% |
985,100
|
$9,697,526 |
Ecor1 Capital, Llc |
Non-Executive |
Zymeworks Inc. (ZYME)
|
2023-01-11 |
$7.67 |
53.3% |
1,026,300
|
$7,874,083 |
Ecor1 Capital, Llc |
Non-Executive |
Voyager Therapeutics, Inc. (VYGR)
|
2022-06-23 |
$5.58 |
13.7% |
477,400
|
$2,662,047 |
Ecor1 Capital, Llc |
Non-Executive |
PROTHENA CORP PUBLIC LTD CO (PRTA)
|
2022-05-05 |
$29.02 |
-28.5% |
1,062,736
|
$30,840,599 |
Ecor1 Capital, Llc |
Non-Executive |
ANAPTYSBIO, INC (ANAB)
|
2022-05-05 |
$21.63 |
70.1% |
668,237
|
$14,453,966 |
Ecor1 Capital, Llc |
Non-Executive |
PROTHENA CORP PUBLIC LTD CO (PRTA)
|
2022-01-12 |
$37.50 |
-44.7% |
300,000
|
$11,250,300 |
Ecor1 Capital, Llc |
Non-Executive Director |
ANAPTYSBIO, INC (ANAB)
|
2021-05-04 |
$23.24 |
58.3% |
221,500
|
$5,147,444 |
Ecor1 Capital, Llc |
Non-Executive Director |
ANAPTYSBIO, INC (ANAB)
|
2021-04-27 |
$23.63 |
55.7% |
147,300
|
$3,480,233 |
Ecor1 Capital, Llc |
Non-Executive |
PROTHENA CORP PUBLIC LTD CO (PRTA)
|
2021-03-24 |
$20.75 |
-0.0% |
875,000
|
$18,156,250 |
Ecor1 Capital, Llc |
Non-Executive |
ANAPTYSBIO, INC (ANAB)
|
2021-03-09 |
$18.93 |
94.4% |
3,308,800
|
$62,622,736 |
Ecor1 Capital, Llc |
Non-Executive |
PROTHENA CORP PUBLIC LTD CO (PRTA)
|
2021-02-24 |
$21.24 |
-2.3% |
55,200
|
$1,172,385 |
Ecor1 Capital, Llc |
Non-Executive |
ANAPTYSBIO, INC (ANAB)
|
2021-02-23 |
$25.48 |
44.4% |
29,500
|
$751,657 |
Ecor1 Capital, Llc |
Non-Executive |
PROTHENA CORP PUBLIC LTD CO (PRTA)
|
2021-02-18 |
$3.68 |
464.2% |
44,100
|
$162,103 |
Ecor1 Capital, Llc |
Non-Executive |
PROTHENA CORP PUBLIC LTD CO (PRTA)
|
2021-02-17 |
$21.56 |
-3.8% |
633,340
|
$13,657,270 |
|
|
|
|
|
Return |
Profit / (loss) |
Cost |
|
|
|
Total |
|
36.2% |
$80,985,352 |
$223,713,309 |